Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jul 27, 2026; 18(7): 119397
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.119397
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.119397
Table 2 Comparison of efficacy between the two groups, n (%)
| Group | Case | CR | PR | SD | PD | ORR | DCR |
| TACE group | 60 | 0 (0.0) | 14 (23.3) | 22 (36.7) | 24 (40.0) | 14 (23.3) | 36 (60.0) |
| Combination group | 60 | 0 (0.0) | 22 (36.7) | 12 (20.0) | 26 (43.3) | 22 (36.7) | 46 (76.7) |
| χ2 | - | - | - | - | - | - | 24.144 |
| P value | - | - | - | - | - | - | 0.001 |
- Citation: Xia Q, Shan W, Yan H. Clinical and radiomic characteristics of transarterial chemoembolization combined with immunotherapy in hepatocellular carcinoma. World J Gastrointest Surg 2026; 18(7): 119397
- URL: https://www.wjgnet.com/1948-9366/full/v18/i7/119397.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i7.119397